Get access to our best features
Get access to our best features
Published 2 years ago

‘You’re either naive, stupid or a con man’: The firm using AI to optimize immunology

Summary by Ground News
Noam Solomon founded Immunai with Luis Voloch in 2018. Within four years the company raised $295 and reached a valuation of $1.2 billion. Immunai works on mapping the body's immune system and understanding the different interconnections within it. The process of immunotherapy treatments can take 15 years and cost $2.5 billion.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)